Literature DB >> 17148511

Genomic sweeping for hypermethylated genes.

Liang Goh1, Susan K Murphy, Sayan Muhkerjee, Terrence S Furey.   

Abstract

MOTIVATION: Genes silenced by the aberrent methylation of nearby CpG islands can contribute to the onset or progression of cancer and represent potential biomarkers for diagnosis and prognosis. Relatively few have thus far been validated as hypermethylated in cancer among over 14,000 candidates with promoter region CpG islands. A descriptive set of genes known to be unmethylated in cancer does not exist. This lack of a negative set and a large number of candidates necessitated the development of a new approach to identify novel genes hypermethylated in cancer.
RESULTS: We developed a general method, cluster_boost, that in an imbalanced data setting predicts new minority class members given limited known samples and a large set of unlabeled samples. Synthetic datasets modeled after the hypermethylated genes data show that cluster_boost can successfully identify minority samples within unlabeled data. Using genome sequence features, cluster_boost predicted candidate hypermethylated genes among 14,000 genes of unknown status. In primary ovarian cancers, we determined the methylation status for 15 genes with different levels of support for being hypermethlyated. Results indicate cluster_boost can accurately identify novel genes hypermethylated in cancer. AVAILABILITY: Software and datasets are freely available at http://labs.genome.duke.edu/FureyLab/cluster_boost.php. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17148511     DOI: 10.1093/bioinformatics/btl620

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  11 in total

Review 1.  Linking genome to epigenome.

Authors:  Guo-Cheng Yuan
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2012-02-17

2.  Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer.

Authors:  Noriomi Matsumura; Zhiqing Huang; Seiichi Mori; Tsukasa Baba; Shingo Fujii; Ikuo Konishi; Edwin S Iversen; Andrew Berchuck; Susan K Murphy
Journal:  Genome Res       Date:  2010-12-14       Impact factor: 9.043

3.  Methylation of PRDM2, PRDM5 and PRDM16 genes in lung cancer cells.

Authors:  Shuang-Xiang Tan; Rui-Cheng Hu; Jing-Jing Liu; Yong-Li Tan; Wen-En Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

4.  Enriched transcription factor binding sites in hypermethylated gene promoters in drug resistant cancer cells.

Authors:  Meng Li; Hyun-il Henry Paik; Curt Balch; Yoosung Kim; Lang Li; Tim H-M Huang; Kenneth P Nephew; Sun Kim
Journal:  Bioinformatics       Date:  2008-06-06       Impact factor: 6.937

5.  Cancer DNA methylation: molecular mechanisms and clinical implications.

Authors:  Michael T McCabe; Johann C Brandes; Paula M Vertino
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

6.  Correlating CpG islands, motifs, and sequence variants in human chromosome 21.

Authors:  Leah Spontaneo; Nick Cercone
Journal:  BMC Genomics       Date:  2011-07-27       Impact factor: 3.969

7.  SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis.

Authors:  G E Lind; C Raiborg; S A Danielsen; T O Rognum; E Thiis-Evensen; G Hoff; A Nesbakken; H Stenmark; R A Lothe
Journal:  Oncogene       Date:  2011-04-18       Impact factor: 9.867

8.  A novel k-mer mixture logistic regression for methylation susceptibility modeling of CpG dinucleotides in human gene promoters.

Authors:  Youngik Yang; Kenneth Nephew; Sun Kim
Journal:  BMC Bioinformatics       Date:  2012-03-21       Impact factor: 3.169

9.  Empirical bayes model comparisons for differential methylation analysis.

Authors:  Mingxiang Teng; Yadong Wang; Seongho Kim; Lang Li; Changyu Shen; Guohua Wang; Yunlong Liu; Tim H M Huang; Kenneth P Nephew; Curt Balch
Journal:  Comp Funct Genomics       Date:  2012-08-22

10.  Diagnostic and prognostic utility of a DNA hypermethylated gene signature in prostate cancer.

Authors:  Liang Kee Goh; Natalia Liem; Aadhitthya Vijayaraghavan; Gengbo Chen; Pei Li Lim; Kae-Jack Tay; Michelle Chang; John Soon Wah Low; Adita Joshi; Hong Hong Huang; Emarene Kalaw; Puay Hoon Tan; Wen-Son Hsieh; Wei Peng Yong; Joshi Alumkal; Hong Gee Sim
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.